Andrew Phillips

48.6k total citations · 7 hit papers
563 papers, 27.6k citations indexed

About

Andrew Phillips is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Andrew Phillips has authored 563 papers receiving a total of 27.6k indexed citations (citations by other indexed papers that have themselves been cited), including 425 papers in Infectious Diseases, 268 papers in Virology and 151 papers in Epidemiology. Recurrent topics in Andrew Phillips's work include HIV/AIDS Research and Interventions (354 papers), HIV Research and Treatment (268 papers) and HIV/AIDS drug development and treatment (244 papers). Andrew Phillips is often cited by papers focused on HIV/AIDS Research and Interventions (354 papers), HIV Research and Treatment (268 papers) and HIV/AIDS drug development and treatment (244 papers). Andrew Phillips collaborates with scholars based in United Kingdom, United States and Denmark. Andrew Phillips's co-authors include Jens Lundgren, Caroline Sabin, Peter Reiss, Antonella d’Arminio Monforte, Ole Kirk, Amanda Mocroft, Margaret Johnson, Rainer Weber, Wafaa El‐Sadr and Nina Friis‐Møller and has published in prestigious journals such as Science, The Lancet and JAMA.

In The Last Decade

Andrew Phillips

544 papers receiving 26.7k citations

Hit Papers

Prognosis of HIV-1-infected patients starting highly acti... 1994 2026 2004 2015 2002 2003 2014 2008 1994 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
    2002 1.2k citations Andrew Phillips, Antonella d’Arminio Monforte et al. The Lancet profile →
  2. Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
    2003 802 citations Nina Friis‐Møller, Rainer Weber et al. AIDS profile →
  3. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
    2014 689 citations Colette Smith, Lene Ryom et al. The Lancet profile →
  4. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration
    2008 675 citations Caroline Sabin, Signe Westring Worm et al. The Lancet profile →
  5. Why do people sue doctors? A study of patients and relatives taking legal action
    1994 484 citations Andrew Phillips et al. The Lancet profile →
  6. Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study
    2009 481 citations Signe Westring Worm, Caroline Sabin et al. The Journal of Infectious Diseases profile →
  7. HIV infection
    2015 405 citations Andrew Phillips et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Phillips United Kingdom 81 18.5k 12.3k 8.7k 8.2k 1.9k 563 27.6k
Richard D. Moore United States 93 16.3k 0.9× 6.4k 0.5× 5.2k 0.6× 12.3k 1.5× 3.4k 1.8× 635 30.6k
Antonella d’Arminio Monforte Italy 67 14.6k 0.8× 9.5k 0.8× 8.8k 1.0× 6.7k 0.8× 823 0.4× 485 21.9k
Joseph J. Eron United States 83 20.8k 1.1× 17.1k 1.4× 3.8k 0.4× 7.0k 0.9× 1.7k 0.9× 465 27.9k
Caroline Sabin United Kingdom 85 15.7k 0.8× 10.2k 0.8× 10.2k 1.2× 9.9k 1.2× 776 0.4× 611 28.0k
Michael S. Saag United States 84 19.4k 1.0× 15.5k 1.3× 4.7k 0.5× 9.5k 1.2× 1.4k 0.7× 328 28.8k
Jens Lundgren Denmark 91 19.9k 1.1× 11.3k 0.9× 11.7k 1.3× 12.0k 1.5× 624 0.3× 678 33.1k
Wafaa El‐Sadr United States 68 13.6k 0.7× 5.4k 0.4× 7.7k 0.9× 7.1k 0.9× 2.5k 1.3× 364 19.8k
Scott D. Holmberg United States 73 14.4k 0.8× 7.3k 0.6× 4.7k 0.5× 13.5k 1.6× 2.1k 1.1× 200 26.9k
Margaret A. Fischl United States 62 16.5k 0.9× 12.5k 1.0× 3.4k 0.4× 6.8k 0.8× 834 0.4× 268 23.5k
Diane V. Havlir United States 68 15.6k 0.8× 11.7k 1.0× 3.0k 0.3× 6.8k 0.8× 1.5k 0.8× 390 22.3k

Countries citing papers authored by Andrew Phillips

Since Specialization
Citations

This map shows the geographic impact of Andrew Phillips's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Phillips with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Phillips more than expected).

Fields of papers citing papers by Andrew Phillips

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Phillips. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Phillips. The network helps show where Andrew Phillips may publish in the future.

Co-authorship network of co-authors of Andrew Phillips

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Phillips. A scholar is included among the top collaborators of Andrew Phillips based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Phillips. Andrew Phillips is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hickey, Matthew D., James Ayieko, Jane Kabami, et al.. (2025). Cost-effectiveness of leveraging existing HIV primary health systems and community health workers for hypertension screening and treatment in Africa: An individual-based modeling study. PLoS Medicine. 22(1). e1004531–e1004531. 1 indexed citations
2.
3.
Pickles, Michael, Joseph Larmarange, Kate M. Mitchell, et al.. (2024). From conceptualising to modelling structural determinants and interventions in HIV transmission dynamics models: a scoping review and methodological framework for evidence-based analyses. BMC Medicine. 22(1). 404–404. 2 indexed citations
4.
Mbuagbaw, Lawrence, Bluma Brenner, Diego Cecchini, et al.. (2023). Checklist for studies of HIV drug resistance prevalence or incidence: rationale and recommended use. The Lancet HIV. 10(10). e684–e689. 5 indexed citations
5.
Miners, Alec, Fiona Lampe, Valentina Cambiano, et al.. (2023). Estimating the hospital costs of care for people living with HIV in England using routinely collected data. HIV Medicine. 24(11). 1115–1125. 1 indexed citations
6.
Chammartin, Frédérique, Sara Lodi, Roger Logan, et al.. (2021). Risk for Non–AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy. Annals of Internal Medicine. 174(6). 768–776. 16 indexed citations
7.
Abongomera, George, Sylvia Kiwuwa-Muyingo, Paul Revill, et al.. (2017). Impact of decentralisation of antiretroviral therapy services on HIV testing and care at a population level in Agago District in rural Northern Uganda: results from the Lablite population surveys. International Health. 9(2). 91–99. 8 indexed citations
8.
9.
Yen, Po‐Yin, Andrew Phillips, Mary Kennedy, & Sarah Collins. (2017). Nursing Informatics Competency Assessment for the Nurse Leader. JONA The Journal of Nursing Administration. 47(5). 271–277. 21 indexed citations
10.
Sewell, Janey, Ada Miltz, Fiona Lampe, et al.. (2017). Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics. International Journal of Drug Policy. 43. 33–43. 166 indexed citations
11.
Smith, Colette, Lene Ryom, Rainer Weber, et al.. (2014). Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. The Lancet. 384(9939). 241–248. 689 indexed citations breakdown →
12.
Worm, Signe Westring, Mark Bower, Peter Reiss, et al.. (2013). Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: a cohort study. BMC Infectious Diseases. 13(1). 471–471. 58 indexed citations
13.
Lodi, Sara, Andrew Phillips, Sarah Fidler, et al.. (2013). Role of HIV Infection Duration and CD4 Cell Level at Initiation of Combination Anti-Retroviral Therapy on Risk of Failure. PLoS ONE. 8(9). e75608–e75608. 7 indexed citations
14.
Pezzotti, Patrizio, Marilena Pappagallo, Andrew Phillips, et al.. (2001). Response to Highly Active Antiretroviral Therapy According to Duration of HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(5). 473–479. 16 indexed citations
15.
Moore, Antonia L., Arvind Vashisht, Caroline Sabin, et al.. (2001). Reduced bone mineral density in HIV-positive individuals. AIDS. 15(13). 1731–1733. 108 indexed citations
16.
Kirk, Ole, Amanda Mocroft, Christian Pradier, et al.. (2001). Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir. AIDS. 15(8). 999–1008. 10 indexed citations
17.
Miller, Veronica, Andrew Phillips, Schlomo Staszewski, et al.. (1998). Dual Resistance to Zidovudine and Lamivudine in Patients Treated with Zidovudine‐Lamivudine Combination Therapy: Association with Therapy Failure. The Journal of Infectious Diseases. 177(6). 1521–1532. 74 indexed citations
18.
Phillips, Andrew, A. G. Shaper, & Peter H. Whincup. (1989). ASSOCIATION BETWEEN SERUM ALBUMIN AND MORTALITY FROM CARDIOVASCULAR DISEASE, CANCER, AND OTHER CAUSES. The Lancet. 334(8677). 1434–1436. 358 indexed citations
19.
Pocock, Stuart, A. G. Shaper, Andrew Phillips, Mary Walker, & T. P. Whitehead. (1986). High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men.. BMJ. 292(6519). 515–519. 102 indexed citations
20.
Pocock, Stuart, A. G. Shaper, Andrew Phillips, Mary Walker, & T. P. Whitehead. (1986). High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men. BMJ. 292(6526). 1013.2–1014. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard D. Moore Breakdown of academic impact, for papers by Antonella d’Arminio Monforte Breakdown of academic impact, for papers by Joseph J. Eron Breakdown of academic impact, for papers by Caroline Sabin Breakdown of academic impact, for papers by Michael S. Saag Breakdown of academic impact, for papers by Jens Lundgren Breakdown of academic impact, for papers by Wafaa El‐Sadr Breakdown of academic impact, for papers by Scott D. Holmberg Breakdown of academic impact, for papers by Margaret A. Fischl Breakdown of academic impact, for papers by Diane V. Havlir
Rankless by CCL
2026